Taiwan FDA approved Ever Supreme’s compassionate use on Autologous umbilical cord mesenchymal stem cells to treat Covid-19

Taiwan FDA approved Ever Supreme’s compassionate use on Autologous umbilical cord mesenchymal stem cells to treat Covid-19

Ever Supreme applied compassionate use of allogeneic umbilical cord mesenchymal stem cells (UMSC01) to Taiwan FDA for treating patients with new coronavirus (COVID-19) infection, and was approved by TFDA on April 9, 2020 (TFDA Medical No. 1090112724).

BACK